3rd Science|Business Sector Day: Health & Life Sciences – Future-proofing medicines.
In April this year, the European Commission issued its proposals for a comprehensive revision of the EU’s basic pharmaceutical legislation. Reflecting key lessons learned from COVID, the proposals seek to create an “innovation-and competitiveness-friendly” landscape in Europe for biomedical research and medicines development, while ensuring greater resilience and autonomy in the event of future health crises and addressing the sector’s environmental footprint. Yet various R&D stakeholders […]
